Truvian Health Raises $74M for Blood Testing Platform, Funding to Drive Regulatory Compliance, Manufacturing, and Sales
Truvian Health Raises $74M in Funding
Truvian Health raises $74M to develop blood testing platform
Truvian Health (Linkedin), a biotechnology research company based in the United States, has secured $74 million in funding to advance their automated blood testing platform. This innovative solution allows routine blood tests to be conducted in clinics, doctor's offices, and pharmacies, revolutionizing healthcare services.
Funding Amount: $74 million
Industry: Biotechnology Research
Employee Count: 51-200
CEO: Jay Srinivasan (CEO Linkedin)
What Truvian Health needs to buy: Truvian Health is seeking partnerships with regulatory compliance experts, manufacturers for instrument and consumable production, and marketing and sales support. Companies specializing in healthcare technology, pharmaceutical retail, and medical laboratory services are ideal collaborators to help Truvian Health achieve FDA clearance, scale production, and expand their market reach.